Trial Profile
A Study Evaluating Effect Of Tofacitinib Plus Methotrexate On Subclinical Atherosclerosis In Methotrexate-Resistant Rheumatoid Arthritis Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Jan 2017
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary)
- Indications Cardiovascular disorders; Rheumatoid arthritis
- Focus Therapeutic Use
- 26 Jan 2017 New trial record